CVS HEALTH Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B |
| Cost of revenue | $221.2B | $206.3B | $217.1B | $196.9B | $175.8B |
| Operating income | $4.7B | $8.5B | $13.7B | $8.0B | $13.3B |
| Interest expense | $3.1B | $3.0B | $2.7B | $2.3B | $2.5B |
| Pretax income | $2.1B | $6.1B | $11.2B | $5.8B | $10.5B |
| Income tax expense | $408.0M | $1.6B | $2.8B | $1.5B | $2.5B |
| Net income | $1.8B | $4.6B | $8.3B | $4.3B | $8.0B |
| Balance Sheet | |||||
| Cash and equivalents | $8.5B | $8.6B | $8.2B | $12.9B | $9.4B |
| Current assets | $74.7B | $68.6B | $67.9B | $65.6B | $60.0B |
| Total assets | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B |
| Current liabilities | $88.7B | $84.6B | $79.2B | $69.4B | $67.8B |
| Total liabilities | $178.2B | $177.5B | $173.1B | $156.5B | $157.6B |
| Total debt | $63.7B | $63.3B | $60.6B | $51.3B | $55.4B |
| Stockholders' equity | $75.2B | $75.6B | $76.5B | $71.5B | $75.1B |
| Cash Flow Statement | |||||
| Cash from operations | $10.6B | $9.1B | $13.4B | $16.2B | $18.3B |
| Depreciation and amortization | $4.6B | $4.6B | $4.4B | $4.2B | $4.5B |
| Stock-based compensation | $535.0M | $540.0M | $588.0M | $447.0M | $484.0M |
| Capital expenditure | $2.8B | $2.8B | $3.0B | $2.7B | $2.5B |
| Free cash flow | $7.8B | $6.3B | $10.4B | $13.4B | $15.7B |
| Dividends paid | $3.4B | $3.4B | $3.1B | $2.9B | $2.6B |
| Share repurchases | $0 | $3.0B | $2.0B | $3.5B | $0 |
| Impairments | $5.7B | $0 | $152.0M | $0 | $431.0M |
Shares outstanding 1.3B · Free float 96.3%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.